AZTA vs PATH · rev $159.2M vs P/E 19, rev $1.61B
Azenta Inc (AZTA) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Azenta Inc (AZTA) is a medical instruments & supplies company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported AZTA revenue for 2025-09-30 was $159.2M. Net income was $50.9M. Revenue was up 10.7% from 2025-06-30 to 2025-09-30. AZTA currently screens at market cap $1.05B.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
AZTA currently screens at market cap $1.05B. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the AZTA and PATH stock pages for the full models.
Not investment advice.